Diligence memo · auto-generated · as of July 3, 2026
Coherus BioSciences, Inc.
Coherus BioSciences, Inc. has raised $161M over 8 rounds; too few niche peers to rank its valuation yet.
Businessfiled
Coherus BioSciences, Inc. operates in Biotech / Pharma, based in REDWOOD CITY.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Coherus BioSciences, Inc. has raised $161M in disclosed capital across 8 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $56M on 2014-05-09.
Most recent recorded round closed around 2017-12-01.
Valuation (modeled)modeled
Provath models Coherus BioSciences, Inc. at approximately $258M (range $22M–$681M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Historic cadence: a new round about every 10 months.
Last raise 8.6 yr ago; this sector typically re-raises about every 15 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.5× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 96% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 83% of those peers.
Peoplefiled
24 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.